Skip to main content

Table 1 Baseline clinical and laboratory characteristics of patients with and without recovery in LVEF

From: A novel marker of persistent left ventricular systolic dysfunction in patients with peripartum cardiomyopathy: monocyte count- to- HDL cholesterol ratio

Characteristic

Nonrecovery Group

Recovery Group

P value

(n = 35)

(n = 29)

Age at diagnosis (years) (SD)

29.8 ± 6,0

28.5 ± 6,0

0.417

Hypertension, n (%)

5 (14.3)

5 (17.2)

0.746

Dyslipidemia, n (%)

8 (23.5)

3 (10.3)

0.169

CAD, n (%)

0 (0)

2 (7.1)

0.124

Diabetes, n (%)

3 (9.1)

0 (0)

0.102

COPD, n (%)

2 (6.3)

0 (0)

0.178

Family history, (%)

6 (18.8)

1 (3.6)

0.109

ICD, n (%)

15 (42.8)

5 (17.2)

0.043

True ICD therapy, n (%)

4 (11.4)

1 (3.4)

0.236

ACEI / ARB, n (%)

29 (82.9)

24 (82.8)

0.992

B-blockers, n (%)

28 (80)

23 (79.3)

0.946

Digoxin, n (%)

11 (31.4)

7 (24.1)

0.518

Heart rate (bpm)

82.3 ± 14.1

81.4 ± 13.9

0.793

Systolic blood pressure (mmHg)

120.1 ± 13.4

121.7 ± 11.9

0.610

Diastolic blood pressure (mmHg)

77.4 ± 5.9

77.6 ± 5.6

0.843

Body- mass index (kg/m2)

24.0 ± 4.7

25.0 ± 4.7

0.377

Baseline LV EF a (%)

29.0(21.0–35.0)

36.0(33.5–39.5)

< 0.001

Uric acid a (mg/dl)

6.8(4.9–8.8)

5.6 (4.8–6.8)

0.076

Urea a (mg/dl)

30.0(20.0–38.0)

23.5(19.0–27.7)

0.053

Creatinine a (mg/dl)

0.74(0.63–0.94)

0.71(0.59–0.82)

0.131

GFR(SD) (mL/m2)

94.0 ± 35.5

102.1 ± 29.9

0.455

Total cholesterol a (mg/dl)

171(132–212)

159(144–184)

0.278

Triglyceride a (mg/dl)

136.0(88.0–180.0)

97.0(84.0–128.0)

0.049

LDL-C a (mg/dl)

102.0(74.0–13.0)

85.0(73.5–112.5)

0.200

HDL-C (mg/dl) (SD)

39.9 ± 14.6

52.0 ± 13.2

0.001

Albumin (mg/dl) (SD)

4.0 ± 0.6

4.1 ± 0.6

0.390

CRP a (mg/dl)

6.2(2.4–19)

2.1(0.9–3.3)

< 0.001

Hemoglobin (g/dl) (SD)

12.5 ± 1.7

12.8 ± 1.9

0.53

WBC a (× 103 μL)

8.3(7.2–10.5)

7.5(5.8–8.5)

0.021

Neutrophil a (×103 μL)

5.0(4.1–6.6)

4.8(3.7–5.3)

0.113

Lymphocyte a (× 103 μL)

2.4(1.8–2.9)

2.0(1.4–2.6)

0.084

Monocyte (×103 μL) (SD)

0.63 ± 0.18

0.47 ± 0.14

< 0.001

Monocyte / HDL ratio a

15.5(10.8–28.5)

8.8(6.4–13.8)

< 0.001

MHR > 9.73, n (%)

31 (88.6)

11 (37.9)

< 0.001

  1. Bold data displays statisticially significant difference (p < 0.05)
  2. ACEI angiotensin-convertingenzyme inhibitör, ARB angiotensin receptor blocker, CAD coronary artery disease, COPD chronic obstructive pulmonary disease, CRP C-reactive protein, GFR glomeruler filtration rate, HDL-C high-density lipoprotein cholesterol, ICD intracardiac defibrillator, LDL-C low-density lipoprotein cholesterol, LVEF left ventricular ejection fration,MHR monocyte to HDL cholesterol ratio, SD standart deviation, WBC white blood cell
  3. aComparison was made using Mann-Whitney U test at P < 0.05, and these values were described by median with inter-quartile range (25th and 75th percentile)
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us